Michael R. King receives distinguished excellence in leadership award

Michael R. King, the J. Lawrence Wilson Professor of Engineering, has been selected to receive the 2024 BMES CMBE Christopher Jacobs Award for Excellence in Leadership for his work in the cellular and molecular bioengineering community.

Professor Michael R. King.

King holds a secondary appointment in radiology and radiological sciences and he is an internationally renowned researcher and scholar. He works at the interface among cellular engineering, drug delivery and nanotechnology.

King was a co-founder of StemCapture and CellTraffix. His in vivo stem cell extraction device detects, isolates and targets rare stem and cancer cells in complex mixtures of bodily fluids. He is the lead inventor on four U.S. patents in the field of cellular and molecular bioengineering and six U.S. patent applications.

He has co-written two successful textbooks and edited several research monographs. King also is the editor-in-chief of Cellular and Molecular Bioengineering, a journal of the Biomedical Engineering Society.

Among his recognitions are a National Science Foundation CAREER Award, a James D. Watson Investigator Award, a Whitaker Foundation Whitaker Investigator, and two teaching awards. He is a Fellow of the American Association for the Advancement of Science, the American Institute for Medical and Biological Engineering (AIMBE), the Biomedical Engineering Society, the International Academy of Biological Engineering, and the National Academy of Engineering. He serves as the Chair of the AIMBE College of Fellows.

The Christopher Jacobs Award is named in honor of Professor Chris Jacobs, Ph.D., whose vision and leadership have greatly impacted the field of cellular and molecular bioengineering. It was awarded at the annual conference of the Cellular and Molecular Bioengineering (CMBE) Special Interest Group (SIG) of BMES, held January 2 – 6, 2024, in San Juan, Puerto Rico.

Contact: Lucas Johnson, lucas.l.johnson@vanderbilt.edu